Literature DB >> 15070265

Procedures for establishing and maintaining consistent air-kerma strength standards for low-energy, photon-emitting brachytherapy sources: recommendations of the Calibration Laboratory Accreditation Subcommittee of the American Association of Physicists in Medicine.

Larry A DeWerd1, M Saiful Huq, Indra J Das, Geoffrey S Ibbott, William F Hanson, Thomas W Slowey, Jeffrey F Williamson, Bert M Coursey.   

Abstract

Low dose rate brachytherapy is being used extensively for the treatment of prostate cancer. As of September 2003, there are a total of thirteen 125I and seven 103Pd sources that have calibrations from the National Institute of Standards and Technology (NIST) and the Accredited Dosimetry Calibration Laboratories (ADCLs) of the American Association of Physicists in Medicine (AAPM). The dosimetry standards for these sources are traceable to the NIST wide-angle free-air chamber. Procedures have been developed by the AAPM Calibration Laboratory Accreditation Subcommittee to standardize quality assurance and calibration, and to maintain the dosimetric traceability of these sources to ensure accurate clinical dosimetry. A description of these procedures is provided to the clinical users for traceability purposes as well as to provide guidance to the manufacturers of brachytherapy sources and ADCLs with regard to these procedures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070265     DOI: 10.1118/1.1645681

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  5 in total

1.  A dosimetric uncertainty analysis for photon-emitting brachytherapy sources: report of AAPM Task Group No. 138 and GEC-ESTRO.

Authors:  Larry A DeWerd; Geoffrey S Ibbott; Ali S Meigooni; Michael G Mitch; Mark J Rivard; Kurt E Stump; Bruce R Thomadsen; Jack L M Venselaar
Journal:  Med Phys       Date:  2011-02       Impact factor: 4.071

2.  Dosimetric consideration of individual 125I source strength measurement and a large-scale comparison of that measured with a nominal value in permanent prostate implant brachytherapy.

Authors:  Yutaka Takahashi; Akira Ito; Iori Sumida; Takuyo Kozuka; Kotaro Gomi; Takayuki Nose; Teruo Ito; Takashi Yamashita
Journal:  Radiat Med       Date:  2006-12-25

3.  A directional 103Pd brachytherapy device: Dosimetric characterization and practical aspects for clinical use.

Authors:  Mark J Rivard
Journal:  Brachytherapy       Date:  2016-12-28       Impact factor: 2.362

4.  Source strength determination in iridium-192 and cobalt-60 brachytherapy: A European survey on the level of agreement between clinical measurements and manufacturer certificates.

Authors:  Javier Vijande; Åsa Carlsson Tedgren; Facundo Ballester; Dimos Baltas; Panagiotis Papagiannis; Mark J Rivard; Frank-André Siebert; Larry De Werd; Jose Perez-Calatayud
Journal:  Phys Imaging Radiat Oncol       Date:  2021-07-30

5.  HDR and PDR 192Ir source activity control procedures, as the part of the quality assurance system at Brachytherapy Department of Greater Poland Cancer Centre.

Authors:  Grzegorz Zwierzchowski; Barbara Błasiak; Patrycja Stefaniak; Grzegorz Bielęda
Journal:  J Contemp Brachytherapy       Date:  2009-10-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.